Cyclerion Therapeutics, Inc.
sGC stimulators
Last updated:
Abstract:
Compounds of Formulae I' and I are described, which are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds are also useful for treating, preventing or managing various disorders that are herein disclosed. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
13 Mar 2020
Issue date:
28 Dec 2021